Rebecca Carmi
A pioneering pediatrician and medical geneticist who advanced hereditary-disease research, Israeli higher education and women's leadership
Professor Rebecca Carmi is an Israeli pediatrician, medical geneticist and academic leader whose career connected advanced medicine with public responsibility and institution-building. For decades she worked at Ben-Gurion University of the Negev and Soroka University Medical Center, researching hereditary disease among the Arab-Bedouin population of the Negev. She also helped shape the university's scientific infrastructure, promoted women in medicine and academia, and served in national forums concerned with health, science and security.
From Military Service to Medicine and Genetics
Carmi was born and raised in Zikhron Ya'akov. She served in the Israel Defense Forces as an officer, attaining the rank of captain, and commanded an officers' course for academic reserve personnel. During the Yom Kippur War, she took part in establishing a unit responsible for locating missing IDF personnel. The experience placed her early in a demanding form of public service requiring organization, precision and sensitivity to families under extreme stress.
After completing her regular service, she began studying biology at the Hebrew University of Jerusalem and then entered its medical school. She trained in pediatrics, neonatology and infant care at Soroka University Medical Center in Beersheba, and continued with specialization in medical genetics at Harvard Medical School in the United States. The combination of clinical pediatrics and genetics shaped a career attentive to the individual patient, the family and the wider community.
Genetic Research and Medical Service in the Negev
Carmi directed the Genetic Institute at Soroka University Medical Center and participated in research and programs aimed at preventing hereditary diseases among the Bedouin population of the Negev. Her scientific work focused on the clinical expression and molecular basis of genetic disorders. In a region with distinctive patterns of inherited disease, locally grounded research could lead to more accurate diagnosis, better genetic counseling and more effective prevention for families.
According to the supplied biographical material, her research resulted in more than 150 publications in medical genetics, the identification of 12 new genes and the description of two new syndromes, one of which is known as Carmi syndrome. Her first academic publication, in 1977, examined carbon-dioxide accumulation in infant cribs and oxygen-delivery hoods, and its possible connection with sudden infant death. From the beginning, her work addressed questions with direct implications for infant safety and clinical practice.
Her research was accompanied by community engagement. Carmi participated in projects seeking to prevent hereditary disease in the Bedouin community and in initiatives promoting women's education there. This combination of genetics, preventive medicine, education and community knowledge illustrates a model of public medicine that treats scientific discovery and social accessibility as complementary responsibilities.
Building Scientific Capacity at Ben-Gurion University
At Ben-Gurion University of the Negev, Carmi held a succession of academic and administrative positions. She contributed to biotechnology initiatives, served as acting chair of the National Institute for Biotechnology in the Negev, and helped develop a research environment linking life sciences, medicine and regional needs. She became a full professor at the age of 45. At the university's School of Medicine, she served among other roles as vice dean for student affairs, and from 1995 held the Kreitman Foundation Chair in Pediatric Genetics.
From 2000 to 2005 she was dean of the Faculty of Health Sciences. During that period she was elected chair of the Association of Israeli Medical School Deans, becoming the first woman in Israel to hold the position. The achievement was significant not only personally: it marked a change in the leadership structure of Israeli academic medicine, where women were becoming central participants in shaping medical education, research and professional policy.
The First Woman to Lead an Israeli Research University
In December 2005, following the retirement of President Avishai Braverman, Carmi was elected president of Ben-Gurion University of the Negev. She became the first woman elected to lead an Israeli research university. She was chosen for a third term in May 2014 and remained president until the end of 2018, when she was succeeded by Professor Daniel Chamovitz.
As president, she led an institution at the heart of Israel's scientific, educational and social life. Ben-Gurion University operates in the Negev, where higher education, healthcare, regional development and relationships with local communities are closely connected. Carmi brought to the presidency the perspective of a physician and researcher, as well as an understanding of the university as a public institution: not simply a place that awards degrees, but a source of research, professional training and opportunity.
From 2010 to 2012 she chaired the Committee of University Heads in Israel. Her public service also included membership in the Rivlin Committee, which examined a special compensation arrangement for employees of the Negev Nuclear Research Center in Dimona who developed cancer after occupational exposure to ionizing radiation, and the committee examining the defense budget, known as the Locker Committee, which submitted its recommendations in July 2015. She was a founding member of the UK-Israel Science Council and served as its co-chair from 2010 to 2017 alongside Professor Raymond Dwek. These roles extended her influence beyond the university and the medical profession into national policy and international scientific cooperation.
Advancing Women in Medicine and Academia
Promoting women's participation and status in professional institutions was a consistent theme in Carmi's public work. In 2011 she chaired the Council for Higher Education's Carmi Team, which addressed the advancement and representation of women in higher-education institutions. In 2015 she headed the Israel Medical Association's task force examining the status of women in medicine.
This work reinforced the example she had already set. Carmi was a physician and researcher who reached the highest levels of academic leadership while also examining the institutional conditions that enable other women to advance. Her impact therefore extends beyond her own appointments to the students, researchers and physicians for whom her career made senior academic leadership more visible and attainable.
Why Rebecca Carmi Merits Inclusion in Moreshet
Rebecca Carmi merits inclusion in Moreshet because her work spans several spheres central to Israeli life: pediatric care, medical research, public health, physician training, university leadership and the advancement of women. Her research in medical genetics helped deepen understanding of hereditary disease in the Negev and demonstrated the value of connecting scientific expertise with the needs of a particular community. Her leadership at Ben-Gurion University marked a breakthrough for women in Israel and strengthened the role of the Negev in the country's scientific and academic life.
Her story also carries broader Jewish and Israeli significance. It shows how medicine, education and science can become instruments of mutual responsibility and nation-building. By documenting her career, Moreshet.com preserves not only professional achievements but also the example of a leader who turned medical knowledge, public service and persistence into lasting influence on institutions and on the people they serve.
